Lung cancer is a disease also called as lung carcinoma, in the body it is a malignant lung tumor which is followed by uncontrolled cell growth in tissues of the lung. This cancer, its tumors can spread to the other parts of body outside the lung. This process is called metastasis. Most cancers which are initially originated from the lung are called primary lung cancers – they are carcinomas. The two main types of the lung cancer are small-cell lung carcinoma ( abbreviate is SCLC) and non-small-cell lung carcinoma (NSCLC).
The most wide-spread symptoms of any type of the lung cancer are following:
- coughing (including coughing up blood)；
- weight loss；
- shortness of breath；
- chest pains.
In the traditional area of treatment of the lung cancer this disease belonhs to the oncology field.
Usual onset of the lung cancerequals around 70 years.
The list if risk behaviour which can have negative consequence such as lung cancer include:
- Abnormal smoking；
- Air pollution and unpleasant environment；
- Genetic factors；
- Radon gas；
- Asbestos etc.
In the traditional area of treatment of the lung cancer experts usually treat this disease using following methods:
According to the non traditional methods if the treatment of the lung cancer, as a professional healer I use:
- Method of overall diagnosis；
- Method of seeking the initial reason of the lung cancer；
- Method of eliminating of its original reason；
- Body cleaning method , which much be used simultaneously with the professional oncology treatment in the special health organisations.
According to the various prognisis , the lung cancer has around 5 years survival rate.
According to the Wikipedia data , just in 2015 year the number of the patients affected by the lung cancer was more than 3.3 million people. Number of deaths in the same year is 1.7 million.
Usually people who do not belong to the healing area, consider that the main reason of lung cancer is due to the abnormal tobacco misuse, and the procentage of these patient is around 85%. About 10–15% of cases occur in people who have never smoked. Being a professional healer who can heal the lung cancer, I am totally sure that the real reason of the lung cancer in not smoking, but genetic and economical reason. Otherwise how can you explain why some people smoke more and some of them smoke less? But both categories can include the risk of obtaining of the lung cancer, or any another type of cancer. Also I am very sure that in the most number of cases economical reason is the second most important reason of the happening of ling cancer. The reason is that nowadays mostly people have high pressure and really stressed just because of money and the lack of them. The genetic possibility can be devwloped by stress and result in the lung cancer of various stages.
During the dialog with the patient , I mostly rely on the pathology reports, because for eliminating the reason, I must know its consequences. Lung cancer may be seen on chest radiographs and computed tomography (CT) scans. The diagnosis is confirmed by biopsy which is usually performed by bronchoscopy or CT-guidance.
Healee says: The ways to avoid the lung cancer
Usually in traditional treatment area various scientists consider that to avoid the happening of lung cancer or another type of cancer you should avoid such situations as:
- Air pollution
These are considered to be the primary methods of prevention . Being wxperienced healer, I consider that to avoit not only the lung cancer, but also any type of malady you must follor there recommendations:
- Do not smoke, drink alcohol, misuse drugs and etc. Any unpleasant, atrocious and hazadous habits should not be at all. They are highly necessary to be kept off, deflected, nullified from the regular life.
- Try you best to save money and provide economocal stability to avoid and keep off the most common reason of any stress-stress – the lack of money.
- Be religious, follow moral laws and try to cultivate good and kind personality towards yourself and surrounding people.
- Be helpful. You should be happy to help other people whatever situation happened.
- Do the sport. Sport can help you to be confident and avoid the stress.
- Do yoga. Yoga also can provide the huge help in the purpose of self control and avoiding of the stress.
- Try to build yout life unhazadous , noncrucial and risk free. Do not do any life -threatening or insecure activities, even if it is walking the road on red light.
Treatment of the lung cancer : comparison with the treatment of lung cancer by healer
Treatment of the lung cancer depends on the type of cancer, the stage (degree of spread), and the person’s overall health. In traditional area various and numerous experts suppose that most cases of lung cancer are not curable. Common and regular treatments of lung cancer include surgery, chemotherapy, and radiotherapy. NSCLC is sometimes treated with surgery, whereas SCLC usually responds better to chemotherapy and radiotherapy.
As a professional healer, I heal the lunh cancer using my own way with the elements of parapsychology and specific knowledge. On the contrary to the traditional experts points of view I consider lung cancer to be utterly curable without any questions. I realise what elements tgis type of disease actually consist of and what should you do to eliminate there elements entirely. For both small cell lung cancer and non small cell lung cancer I am accustomed to use same methods to deal with, the difference is that in case of the small cell lung cancer I heal slowly and accurately, in case of the non small sell lung cancer I have to act quickly and the methods are more complicated.
Detestable and fearsome damage from lung cancer
In 2012, lung cancer happened in 1.8 million people and resulted in 1.6 million deaths.This makes it the most common cause of cancer-related death in men and second most common in women after breast cancer. The most common age at diagnosis is 70 years. Overall, 17.4% of people in the United States diagnosed with lung cancer survive five years after the diagnosis, while outcomes on average are worse in the developing world.
According to my personal and individual opinion, based on the long-term experience,
I consider the damage from lung cancer same as from any other type of cancer to be absolutely severe, odious, direful and terrible now for only one person , but also for all his family. The damage from this sickness is able to destroy the whole family and its generation. As a healer, I am sure that this sickness must be eliminated not only by surgery or chemoyherapy, but also spiritually, from the inner side. Both sickness and its reasons must be solved entirely together.
Abominable and dreadful prognosis about the lung cancer by usual experts
Of all people with lung cancer in the US, 16.8% survive for at least five years after diagnosis. In England and Wales, between 2010 and 2011, overall five-year survival for lung cancer was estimated at 9.5%. Outcomes are generally worse in the developing world. Stage is often advanced at the time of diagnosis. At presentation, 30–40% of cases of NSCLC are stage IV, and 60% of SCLC are stage IV. Survival for lung cancer falls as the stage at diagnosis becomes more advanced: the English data suggest that around 70% of patients survive at least a year when diagnosed at the earliest stage, but this falls to just 14% for those diagnosed with the most advanced disease.
Prognostic factors in NSCLC include presence of pulmonary symptoms, large tumor size (>3 cm), nonsquamous cell type (histology), degree of spread (stage) and metastases to multiple lymph nodes, and vascular invasion. For people with inoperable disease, outcomes are worse in those with poor performance status and weight loss of more than 10%. Prognostic factors in small cell lung cancer include performance status, gender, stage of disease, and involvement of the central nervous system or liver at the time of diagnosis.
For NSCLC, the best prognosis is achieved with complete surgical resection of stage IA disease, with up to 70% five-year survival. People with extensive-stage SCLC have an average five-year survival rate of less than 1%. The average survival time for limited-stage disease is 20 months, with a five-year survival rate of 20%.
According to data provided by the National Cancer Institute, the median age at diagnosis of lung cancer in the United States is 70 years, and the median age at death is 72 years.
Positive prignosis about the lung cancer by adept healer
Being experienced and proficient in this area healer who knows almost all the ways to treat the most arduous, tough unmanageable, gruelling, severe, hard, cumbersome, burdensome, painstaking, challenging, complicated and problematic diseases in this world, my prognosis is very exact – cancer can be eliminated successfully and entirely not only from the patients body , but also from his and his family life. My prognosis for the stopping the disease to progress usually can take from one week to one month, the body cleaning takes 2-3 years. And also body cleaning does not influence the regular patient’s life. And there can not be any prognosis about death, I will fight for your life and I am able to win this fight. All the prognosis about the cancer of mine are positive.
Lung cancer history
Lung cancer wa not wide-spread at all before the appearing of cigarette smoking; it was not even recognized as a distinct disease until 1761. Different aspects of lung cancer were described in 1810. Malignant lung tumors made up only 1% of all cancers seen at autopsy in 1878, but had risen to 10–15% by the early 1900s. Case reports in the medical literature numbered only 374 worldwide in 1912,but a review of autopsies showed the incidence of lung cancer had increased from 0.3% in 1852 to 5.66% in 1952. In Germany in 1929, physician Fritz Lickint recognized the link between smoking and lung cancer, which led to an aggressive antismoking campaign. The British Doctors’ Study, published in the 1950s, was the first solid epidemiological evidence of the link between lung cancer and smoking. As a result, in 1964 the Surgeon General of the United States recommended smokers should stop smoking.
The connection with radon gas was first recognized among miners in the Ore Mountains near Schneeberg, Saxony. Silver has been mined there since 1470, and these mines are rich in uranium, with its accompanying radium and radon gas. Miners developed a disproportionate amount of lung disease, eventually recognized as lung cancer in the 1870s. Despite this discovery, mining continued into the 1950s, due to the USSR’s demand for uranium. Radon was confirmed as a cause of lung cancer in the 1960s.
The first successful pneumonectomy for lung cancer was performed in 1933. Palliative radiotherapy has been used since the 1940s. Radical radiotherapy, initially used in the 1950s, was an attempt to use larger radiation doses in patients with relatively early-stage lung cancer, but who were otherwise unfit for surgery.In 1997, continuous hyperfractionated accelerated radiotherapy was seen as an improvement over conventional radical radiotherapy. With small-cell lung carcinoma, initial attempts in the 1960s at surgical resectionand radical radiotherapy were unsuccessful. In the 1970s, successful chemotherapy regimens were developed.
Lung cancer research
Current research directions for lung cancer treatment include immunotherapy, which encourages the body’s immune system to attack the tumor cells, epigenetics, and new combinations of chemotherapy and radiotherapy, both on their own and together. Many of these new treatments work through immune checkpoint blockade, disrupting cancer’s ability to evade the immune system.
Ipilimumab blocks signaling through a receptor on T cells known as CTLA-4 which dampens down the immune system. It has been approved by the U.S. Food and Drug Administration for treatment of melanoma and is undergoing clinical trials for both non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC).
Other immunotherapy treatments interfere with the binding of programmed cell death 1 (PD-1) protein with its ligand PD-1 ligand 1 (PD-L1), and have been approved as first- and subsequent-line treatments for various subsets of lung cancers. Signaling through PD-1 inactivates T cells. Some cancer cells appear to exploit this by expressing PD-L1 in order to switch off T cells that might recognise them as a threat. Monoclonal antibodies targeting both PD-1 and PD-L1, such as pembrolizumab, nivolumab, atezolizumab, and durvalumab are currently in clinical trials for treatment for lung cancer.
Epigenetics is the study of small, usually heritable, molecular modifications—or “tags”—that bind DNA and modify gene expression levels. Targeting these tags with drugs can kill cancer cells. Early-stage research in NSCLC using drugs aimed at epigenetic modifications shows that blocking more than one of these tags can kill cancer cells with fewer side effects. Studies also show that giving patients these drugs before standard treatment can improve its effectiveness. Clinical trials are underway to evaluate how well these drugs kill lung cancer cells in humans. Several drugs that target epigenetic mechanisms are in development. Histone deacetylase inhibitors in development include valproic acid, vorinostat, belinostat, panobinostat, entinostat, and romidepsin. DNA methyltransferase inhibitors in development include decitabine, azacytidine, and hydralazine.
The TRACERx project is looking at how NSCLC develops and evolves, and how these tumors become resistant to treatment.The project will look at tumor samples from 850 NSCLC patients at various stages including diagnosis, after first treatment, post-treatment, and relapse. By studying samples at different points of tumor development, the researchers hope to identify the changes that drive tumor growth and resistance to treatment. The results of this project will help scientists and doctors gain a better understanding of NSCLC and potentially lead to the development of new treatments for the disease.
For lung cancer cases that develop resistance to epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitors, new drugs are in development. New EGFR inhibitors include afatinib and dacomitinib. An alternative signaling pathway, c-Met, can be inhibited by tivantinib and onartuzumab. New ALK inhibitors include crizotinib and ceritinib. If the MAPK/ERK pathway is involved, the BRAF kinase inhibitor dabrafenib and the MAPK/MEK inhibitor trametinib may be beneficial.
Lung cancer stem cells are often resistant to conventional chemotherapy and radiotherapy. This may lead to relapse after treatment. New approaches target protein or glycoprotein markers that are specific to the stem cells. Such markers include CD133, CD90, ALDH1A1, CD44 and ABCG2. Signaling pathways such as Hedgehog, Wnt and Notch are often implicated in the self-renewal of stem cell lines. Thus treatments targeting these pathways may help to prevent relapse.
Read also: Alternative treatment for lung cancer